Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/301230 stock hub

SHE/301230 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/301230is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.9B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/301230

In the news

Latest news · SHE/301230

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E133.8

P25 23.5P50 41.3P75 83.2

ROE4.4

P25 -0.9P50 4.1P75 8.8

ROIC5.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/301230 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

CNY

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,085
Enterprise value	CNY 5.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE1000065Q9
Last refreshed	2026-05-10
Market cap	CNY 5.9B
Price	CNY 42.64
Price currency	CNY
Rev Per Employee	688,453.79x
Sector	Healthcare
Sic	8731
Symbol	she/301230
Website	https://www.pharmaresources.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.79%
EV Earnings	124.42x
EV/EBIT	119.69x
EV/EBITDA	74.04x
EV/FCF	50.83x
EV/Sales	8.3x
FCF yield	1.92%
P/B ratio	5.69x
P/E ratio	133.75x
P/S ratio	8.48x
PE Ratio3 Y	165.12x
PE Ratio5 Y	150.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.93%
EBITDA Margin	11.16%
FCF margin	16.33%
Gross margin	28.3%
Gross Profit	CNY 195.6M
Gross Profit Growth	29.47%
Gross Profit Growth Q	14.34%
Gross Profit Growth3 Y	2.8%
Gross Profit Growth5 Y	15.1%
Net Income	CNY 46.1M
Net Income Growth	81.57%
Net Income Growth Q	98.59%
Net Income Growth3 Y	-13.83%
Net Income Growth5 Y	-0.49%
Pretax Margin	6.26%
Profit Margin	6.67%
Profit Per Employee	CNY 45,916
ROA	2.26
Roa5y	3.78
ROCE	4.12
ROE	4.44
Roe5y	8.32
ROIC	5.44
Roic5y	10.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	43.1%
Cagr3y	8.36%
EPS Growth	70.68
EPS Growth Q	88.89
EPS Growth3 Y	-19.09
EPS Growth5 Y	-7.35
FCF Growth5 Y	75.36%
OCF Growth	139.75%
OCF Growth3 Y	25.16%
OCF Growth5 Y	32.63%
Revenue Growth	18.53x
Revenue Growth Q	1.69x
Revenue Growth3 Y	11.7x
Revenue Growth5 Y	23.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.52
Assets	CNY 1.3B
Cash	CNY 288.2M
Current Assets	CNY 578.1M
Current Liabilities	CNY 153.8M
Debt	CNY 159.4M
Debt EBITDA	CNY 2.06
Debt Equity	CNY 0.15
Debt FCF	CNY 1.41
Equity	CNY 1B
Liabilities	CNY 285.9M
Long Term Assets	CNY 737.7M
Long Term Liabilities	CNY 132.1M
Net Cash	CNY 128.8M
Net Cash By Market Cap	CNY 2.2
Net Cash Growth	-13.47%
Net Debt EBITDA	CNY -1.67
Net Debt Equity	CNY -0.13
Net Debt FCF	CNY -1.14
Tangible Book Value	CNY 1B
Tangible Book Value Per Share	CNY 7.3
WACC	9.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.76
Inventory Turnover	6.24
Net Working Capital	CNY 169.9M
Quick ratio	2.88
Working Capital	CNY 424.4M
Working Capital Turnover	CNY 1.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.38%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.5
Dividend Years	4
Dividend Yield	1.17%
Ex Div Date	2026-01-13
Last Dividend	CNY 0.1
Payout Frequency	Quarterly
Payout Ratio	143.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	43.07%
200-day SMA	37.89
3Y total return	27.26%
50-day SMA	40.62
50-day SMA vs 200-day SMA	50over200
All Time High	67.97
All Time High Change	-37.27%
All Time High Date	2026-01-14
All Time Low	16.28
All Time Low Change	161.96%
All Time Low Date	2024-02-06
ATR	2.29
Beta	1.05
Beta1y	0.83
Beta2y	1.16
Ch YTD	42.75
High	44.75
High52	67.97
High52 Date	2026-01-14
High52ch	-37.27%
Low	42.5
Low52	28.9
Low52 Date	2025-12-17
Low52ch	47.54%
Ma50ch	4.98%
Price vs 200-day SMA	12.55%
RSI	53.88
RSI Monthly	59.19
RSI Weekly	56.76
Sharpe ratio	1.01x
Sortino ratio	1.77
Total Return	-5.21%
Tr YTD	42.75
Tr1m	6.04%
Tr1w	0.28%
Tr3m	-7.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 47.9M
Operating Income Growth	254.8
Operating Income Growth Q	66.53
Operating Income Growth3 Y	-8.69
Operating Income Growth5 Y	0.32
Operating margin	6.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	73,977,635%
Net Borrowing	-7,653,171
Shares Insiders	13.92%
Shares Institutions	16.46%
Shares Out	137,540,405
Shares Qo Q	7.7%
Shares Yo Y	6.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 112.8M
Average Volume	8,951,902.3x
Bv Per Share	7.36
CAPEX	CNY -54.3M
Ch1m	6.04
Ch1w	0.28
Ch1y	41.38
Ch3m	-7.32
Ch3y	22.91
Ch6m	31.97
Change	-2.27%
Change From Open	-4.57
Close	43.63
Days Gap	2.41
Depreciation Amortization	29,245,167
Dollar Volume	439,654,644
Earnings Date	2026-04-29
EBIT	CNY 47.9M
EBITDA	CNY 77.2M
EPS	CNY 0.32
F Score	6
FCF	CNY 112.8M
FCF EV Yield	1.97x
FCF Per Share	CNY 0.82
Financing CF	-101,008,631
Fiscal Year End	December
Founded	2,007
Graham Number	7.26752
Graham Upside	-82.96
Income Tax	CNY -2.9M
Investing CF	-41,601,891
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2024-06-21
Last Split Type	Forward
Lynch Fair Value	CNY 1.59
Lynch Upside	-96.26
Ma150	37.82
Ma150ch	12.75%
Ma20	41.65
Ma20ch	2.39%
Net CF	23,464,794
Next Earnings Date	2026-08-28
Open	44.68
P FCF Ratio	51.97
P OCF Ratio	35.09
Payment Date	2026-01-13
Position In Range	6.22
Ppne	331,828,102
Price Date	2026-05-08
Price EBITDA	CNY 76
Ptbv Ratio	5.74
Relative Volume	1.15x
Revenue	691,207,610x
Tax By Revenue	-0.41x
Tr6m	32.26%
Volume	10,310,850

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/301230 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.50 annual per share

Payout ratio

+143.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

-5.2%

Next ex-dividend date: 2026-01-13

Performance

SHE/301230 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/301230?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.5%

Share of float held by funds and institutions

Insider ownership

+13.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+6.4%

Negative means the company is buying back shares.

Technical

SHE/301230 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.9

Neutral momentum band

Price vs 200-day MA

+12.6%

50/200-day relationship not available

Beta (5Y)

1.05

Moves roughly with the market

Sharpe ratio

1.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/301230

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/301230 stock rating?

she/301230 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/301230 analysis?

The full report lives at /stocks/she/301230/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/301230?

The latest report frames she/301230 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/301230 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.